Pei Du
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comments on "Randomized, two-arm, non-comparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045".
Journal: International journal of cancer
Published: September 15, 2023
Hsa_circ_0000585 promotes chemoresistance to cis-platin in epithelial cells of ovarian cancer by modulating autophagy.
Journal: Biochemical and biophysical research communications
Published: July 31, 2023
Perspectives of ERCC1 in early-stage and advanced cervical cancer: From experiments to clinical applications.
Journal: Frontiers in immunology
Published: October 09, 2022
Is There an Association Between Contraception and Sexual Dysfunction in Women? A Systematic Review and Meta-analysis Based on Female Sexual Function Index.
Journal: The journal of sexual medicine
Published: February 02, 2020
A Case of Mesh Erosion to the Sigmoid After Laparoscopic Sacrocolpopexy and a Literature Review of Mesh Related Complications.
Journal: Female pelvic medicine & reconstructive surgery
Published: April 27, 2018
Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Journal: DNA and cell biology
Published: May 06, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026